en.unionpedia.org

Formoterol, the Glossary

Index Formoterol

Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD).[1]

Table of Contents

  1. 37 relations: Aclidinium bromide/formoterol, Arformoterol, Astellas Pharma, Asthma, AstraZeneca, Bambuterol, Beta2-adrenergic agonist, Bronchodilator, Budesonide/formoterol, Capsule (pharmacy), Chiesi Farmaceutici, Chronic obstructive pulmonary disease, CYP2A6, CYP2C19, CYP2C9, CYP2D6, Demethylation, Dry-powder inhaler, Enantiopure drug, Fluticasone/salmeterol, Food and Drug Administration, Generic drug, Global Initiative for Asthma, Glucuronidation, Kidney, Liver, Long-acting beta-adrenoceptor agonist, Metered-dose inhaler, Mometasone/formoterol, Mylan, Novartis, Racemic mixture, Salbutamol, Salmeterol, Schering-Plough, Solution (chemistry), Viatris.

  2. Beta2-adrenergic agonists
  3. Drugs developed by Schering-Plough
  4. Formamides

Aclidinium bromide/formoterol

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). Formoterol and Aclidinium bromide/formoterol are drugs developed by AstraZeneca.

See Formoterol and Aclidinium bromide/formoterol

Arformoterol

Arformoterol, sold under the brand name Brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD). Formoterol and Arformoterol are beta2-adrenergic agonists, Formamides, Phenol ethers, Phenols, Phenylethanolamines and Substituted amphetamines.

See Formoterol and Arformoterol

Astellas Pharma

is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of and.

See Formoterol and Astellas Pharma

Asthma

Asthma is a long-term inflammatory disease of the airways of the lungs.

See Formoterol and Asthma

AstraZeneca

AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

See Formoterol and AstraZeneca

Bambuterol

Bambuterol (INN) is a long-acting β adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. Formoterol and Bambuterol are beta2-adrenergic agonists, drugs developed by AstraZeneca and Phenylethanolamines.

See Formoterol and Bambuterol

Beta2-adrenergic agonist

Beta2-adrenergic agonists, also known as adrenergic β2 receptor agonists, are a class of drugs that act on the β2 adrenergic receptor. Formoterol and Beta2-adrenergic agonist are beta2-adrenergic agonists.

See Formoterol and Beta2-adrenergic agonist

Bronchodilator

A bronchodilator or broncholytic (although the latter occasionally includes secretory inhibition as well) is a substance that dilates the bronchi and bronchioles, decreasing resistance in the respiratory airway and increasing airflow to the lungs.

See Formoterol and Bronchodilator

Budesonide/formoterol

Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). Formoterol and Budesonide/formoterol are drugs developed by AstraZeneca.

See Formoterol and Budesonide/formoterol

Capsule (pharmacy)

In the manufacture of pharmaceuticals, encapsulation refers to a range of dosage forms—techniques used to enclose medicines—in a relatively stable shell known as a capsule, allowing them to, for example, be taken orally or be used as suppositories.

See Formoterol and Capsule (pharmacy)

Chiesi Farmaceutici

Chiesi Farmaceutici S.p.A. is an Italian family controlled global pharmaceutical company based in Parma, Emilia-Romagna.

See Formoterol and Chiesi Farmaceutici

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation.

See Formoterol and Chronic obstructive pulmonary disease

CYP2A6

Cytochrome P450 2A6 (abbreviated CYP2A6) is a member of the cytochrome P450 mixed-function oxidase system, which is involved in the metabolism of xenobiotics in the body.

See Formoterol and CYP2A6

CYP2C19

Cytochrome P450 2C19 (abbreviated CYP2C19) is an enzyme protein.

See Formoterol and CYP2C19

CYP2C9

Cytochrome P450 family 2 subfamily C member 9 (abbreviated CYP2C9) is an enzyme protein.

See Formoterol and CYP2C9

CYP2D6

Cytochrome P450 2D6 (CYP2D6) is an enzyme that in humans is encoded by the CYP2D6 gene.

See Formoterol and CYP2D6

Demethylation

Demethylation is the chemical process resulting in the removal of a methyl group (CH3) from a molecule.

See Formoterol and Demethylation

Dry-powder inhaler

A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder.

See Formoterol and Dry-powder inhaler

Enantiopure drug

An enantiopure drug is a pharmaceutical that is available in one specific enantiomeric form.

See Formoterol and Enantiopure drug

Fluticasone/salmeterol

Fluticasone/salmeterol, sold under the brand name Advair among others, is a fixed-dose combination medication containing fluticasone propionate and salmeterol.

See Formoterol and Fluticasone/salmeterol

Food and Drug Administration

The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.

See Formoterol and Food and Drug Administration

Generic drug

A generic drug (or simply generic) is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents.

See Formoterol and Generic drug

Global Initiative for Asthma

The Global Initiative for Asthma (GINA) is a medical guidelines organisation which works with public health officials and health care professionals globally to reduce asthma prevalence, morbidity, and mortality.

See Formoterol and Global Initiative for Asthma

Glucuronidation

Glucuronidation is often involved in drug metabolism of substances such as drugs, pollutants, bilirubin, androgens, estrogens, mineralocorticoids, glucocorticoids, fatty acid derivatives, retinoids, and bile acids.

See Formoterol and Glucuronidation

Kidney

In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation.

See Formoterol and Kidney

Liver

The liver is a major metabolic organ exclusively found in vertebrate animals, which performs many essential biological functions such as detoxification of the organism, and the synthesis of proteins and various other biochemicals necessary for digestion and growth.

See Formoterol and Liver

Long-acting beta-adrenoceptor agonist

Long-acting β adrenoceptor agonists (LABAs) are beta-adrenergic agonists usually prescribed for moderate-to-severe persistent asthma and chronic obstructive pulmonary disease (COPD).

See Formoterol and Long-acting beta-adrenoceptor agonist

Metered-dose inhaler

A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation.

See Formoterol and Metered-dose inhaler

Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. Formoterol and Mometasone/formoterol are drugs developed by Merck & Co..

See Formoterol and Mometasone/formoterol

Mylan

Mylan N.V. was a global generic and specialty pharmaceuticals company.

See Formoterol and Mylan

Novartis

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.

See Formoterol and Novartis

Racemic mixture

In chemistry, a racemic mixture or racemate is one that has equal amounts of left- and right-handed enantiomers of a chiral molecule or salt.

See Formoterol and Racemic mixture

Salbutamol

Salbutamol, also known as albuterol and sold under the brand name Ventolin among others, is a medication that opens up the medium and large airways in the lungs. Formoterol and Salbutamol are drugs developed by Merck & Co., Phenols and Phenylethanolamines.

See Formoterol and Salbutamol

Salmeterol

Salmeterol is a long-acting β2 adrenergic receptor agonist (LABA) used in the maintenance and prevention of asthma symptoms and maintenance of chronic obstructive pulmonary disease (COPD) symptoms. Formoterol and Salmeterol are beta2-adrenergic agonists and Phenylethanolamines.

See Formoterol and Salmeterol

Schering-Plough

Schering-Plough Corporation was an American pharmaceutical company.

See Formoterol and Schering-Plough

Solution (chemistry)

In chemistry, a solution is a special type of homogeneous mixture composed of two or more substances.

See Formoterol and Solution (chemistry)

Viatris

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania.

See Formoterol and Viatris

See also

Beta2-adrenergic agonists

Drugs developed by Schering-Plough

Formamides

References

[1] https://en.wikipedia.org/wiki/Formoterol

Also known as ATC code R03AC13, ATCvet code QR03AC13, Atimos, Atimos modulite, Atock, Eformoterol, Eformoterol fumarate, Foradil, Foradile, Formatris, Formoterol fumarate, Formoterol fumarate dihydrate, Oxeze, Oxeze Turbuhaler, Oxeze Turbuhaler Foradil, Oxis, PERFOROMIST.